We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BBH market cap is 475.63M. The company's latest EPS is USD 15.8343 and P/E is 10.37.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.59M | 3.05M | 3.06M | 3.77M | 3.88M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | -58.29M | 117.15M | 117.2M | -181.28M | 45.87M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 321.65M | 489.78M | 595.48M | 416.43M | 451.18M |
| Total Liabilities | 3.36M | 4.33M | 5.36M | 2.12M | 202k |
| Total Equity | 318.3M | 485.45M | 590.12M | 414.3M | 450.98M |
| Market Cap | 475.63M |
| Price to Earnings Ratio | 10.37 |
| Price to Sales Ratio | 122.5 |
| Price to Cash Ratio | 590.68 |
| Price to Book Ratio | 1.05 |
| Dividend Yield | - |
| Shares Outstanding | 2.9M |
| Average Volume (1 week) | 4.12k |
| Average Volume (1 Month) | 9.61k |
| 52 Week Change | 3.39% |
| 52 Week High | 171.045 |
| 52 Week Low | 142.51 |
| Spread (Intraday) | 11.15 (6.57%) |
| Company Name | VanEck Biotech ETF |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.vaneck.com |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
